April 19, 2012
SeraCare Shareholders Approve Buyout
Shareholders of Milford-based SeraCare Life Sciences have approved the company's acquisition by two affiliates of private equity firm Linden Capital Partners.
Under terms of the agreement, holders of outstanding shares of SeraCare common stock will receive $4 per share after the deal becomes final Friday. SeraCare, a biotech manufacturer, will become part of Project Plasma Holdings Corp. and Project Plasma Merger Corp., both affiliates of Chicago-based Linden Capital. Linden focuses on leveraged buyouts in the health care and life sciences industries.
Meeting Wednesday, SeraCare shareholders also voted to approve compensation arrangements for several of the company's executive officers in connection with the merger.
WBJ Web Partners
Most Recent
Most Recent
0 Comments